Comparing access to orphan medicinal products in Europe

Comparing access to orphan medicinal products in Europe

Abstract Objectives The primary objective of this study was to compare the availability and access of orphan medicinal products (OMPs) in the devolved nations in the United Kingdom (UK), France, Germany, Italy and Spain. Availability is defined as the possibility to prescribe OMPs. Access refers to...

Full description

Bibliographic Details
Main Authors: Bernarda Zamora, Francois Maignen, Phill O’Neill, Jorge Mestre-Ferrandiz, Martina Garau
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Orphan drugs
Access
HTA
Reimbursement
Online Access:http://link.springer.com/article/10.1186/s13023-019-1078-5

Internet

http://link.springer.com/article/10.1186/s13023-019-1078-5

Similar Items